CBOE
Catalysts
Key Risks
The Opportunity
Cboe Global Markets is the company that runs the biggest options exchange in America. Think of it as the toll booth operator on the highway where almost all S&P 500 and VIX options trading must pass through. No one else is allowed to offer these specific products - Cboe has an exclusive deal with S&P Global that gives them a legal monopoly on the most important options contracts in the world. When professional investors want to hedge their portfolios or bet on market volatility, they have no choice but to trade through Cboe's platform.
The business has been growing rapidly because more people than ever are trading options. What used to be a tool mainly for professionals has exploded into the mainstream, partly driven by platforms like Robinhood making options accessible to everyday investors. Same-day options (called 0DTE) have become enormously popular, and Cboe is extending trading hours to capture even more volume from international investors. On top of trading fees, Cboe sells market data subscriptions that provide a growing stream of predictable, recurring revenue - think of it like a SaaS business bolted onto an exchange.
The stock currently trades around $310, and based on a careful analysis of what the business actually earns and could earn going forward, it appears roughly fairly valued - perhaps 3-4% undervalued. That is not a screaming bargain, but it reflects the fact that the market already recognizes this is a high-quality franchise. The company just reported a first half of 2026 where earnings grew over 50% year-over-year, and it has beaten Wall Street estimates in six of its last seven quarters. A new CEO with deep industry experience is streamlining the business by selling off international operations that were not pulling their weight.
The main thing that could go wrong is that options trading volumes normalize after a period of elevated market volatility. Cboe also faces genuine competition in the parts of its business where it does not have exclusive products - its market share in standard stock options dropped two full percentage points in just one year. If that erosion accelerates while volatility cools off, the growth story becomes much less compelling. The CEO transition also adds a layer of execution risk - restructurings do not always go smoothly, and key talent can walk out the door during periods of organizational change.
How we got to $284 - $360
Breakdown
Cboe's Q2 2026 balance sheet shows total assets of $10.61B against total liabilities of $4.98B, yielding book equity of $5.63B or $53.76 per share. At $310 per share, the market values CBOE at roughly 5.8x book - a significant premium, but justified by the nature of the assets. The most critical balance sheet items for an exchange operator are intangible assets and goodwill, largely stemming from the $3.4B BATS acquisition in 2017 and subsequent deals.
These intangibles - particularly the exclusive licensing rights for SPX and VIX index options - are arguably worth substantially more than their amortized book values, given that they generate over $1B in annual operating income. Total debt stands at approximately $1.44B ($649.6M current + $794.2M long-term as of Q2 2026), a very manageable 0.26x D/E ratio. Cash of $2.28B exceeds total debt, meaning the company is effectively net-cash.
The NAV of $53.76 per share is essentially meaningless for an exchange business because the balance sheet dramatically understates the economic value of Cboe's monopoly-like franchise assets. The April 2026 divestiture of Cboe Australia and Canada to TMX Group for $300M against approximately $25M in adjusted EBITDA (12x multiple) [Cboe IR Press Release, April 2026] provides a useful market-based check on what these peripheral businesses are worth versus book. The core U.S. derivatives franchise, which is not for sale, would command a significantly higher multiple.
Free cash flow reached $1.87B on a trailing twelve-month basis, implying an FCF yield of 5.8% at the current market cap of $32.5B. This is strong for a business with Cboe's growth profile. Dividend payments are conservative: $0.72/quarter ($2.88 annualized) represents a 25.9% payout ratio and 0.93% yield.
The 14% dividend increase in Q3 2025 [Cboe Dividend PR, August 2025] marks the 15th consecutive year of increases - a credible commitment to shareholder returns without straining capacity. After dividends consume roughly $300M annually, over $1.5B remains for buybacks, debt management, and strategic investment. Total debt has been reduced from $1.44B (all long-term) at Q4 2024 to a restructured mix with some moved to current, and the company now sits on $2.28B in cash versus roughly $1.44B in total debt - a net cash position.
Capital allocation under new CEO Donohue appears disciplined: the TMX divestiture signals willingness to shed non-core assets at reasonable multiples, and stated intent to redeploy capital into core derivatives, digital assets, and prediction markets [Cboe Shifts to Focus on Growth, Markets Media] suggests growth-oriented but focused deployment. Revenue per employee is approximately $2.84M ($4.71B revenue / 1,661 employees), exceptionally high and characteristic of exchange businesses with enormous operating leverage.
Cboe's financial trajectory from 2016-2025 tells a story of transformation through both acquisition and organic growth. Revenue expanded from $703M (2016) to $4.71B (2025), though much of that jump came from the BATS acquisition in 2017. More relevant is the net revenue (gross profit) trajectory: $566M (2016) to $2.43B (2025), a 4.3x increase.
Net margins have improved from 26.4% (2016) to 26.7% (2025) on a much larger base, demonstrating operating leverage. The 2022 anomaly - where net income plunged to $235M on an asset impairment charge (10-K references AssetImpairmentCharges in the XBRL data) - is notable but appears to be a non-recurring item rather than operational deterioration. Excluding that year, net income has marched steadily from $185.7M (2016) to $1.1B (2025).
EPS grew from $2.27 to $10.42 over the same period, with TTM now at $12.87. Earnings estimate performance is excellent: Cboe beat consensus in 6 of the last 7 reported quarters (Q1 2025 being the lone miss at $2.10 vs $2.13 estimate). The most recent quarters show acceleration - Q1 2026 EPS of $3.66 and Q2 2026 of $3.35 put the H1 run-rate at $7.01, compared to $4.60 in H1 2025, representing 52% growth. ROE of 24% significantly exceeds the peer median of 16.15% and comfortably surpasses a reasonable cost of equity estimate of 8-10% for a low-beta (0.44) financial services company.
Analyst consensus projects 14.6% EPS growth over the next five years, with 28.7% this year moderating to 6.5% next year. The current-year acceleration is partly driven by strong index options volume (ADV up 29% in Q1 2026) [Cboe Q1 2026 Earnings, IR Cboe] and the low-base comparison to the prior CEO transition period. The deceleration to 6.5% next year deserves scrutiny: it may reflect conservatism or genuine concerns about normalizing volatility.
The reverse DCF implies the market is pricing in only 0.5% growth - far below the analyst estimate, suggesting either the market is skeptical or that the current price already reflects a quality premium. Key growth drivers include: (1) secular growth in options trading, particularly 0DTE contracts and extended trading hours [Yahoo Finance, July 2026]; (2) the Data & Access Solutions segment providing recurring, subscription-like revenue; (3) new product launches including prediction markets via an SEC-regulated options wrapper [Cboe Prediction Markets PR Newswire, March 2026]; (4) potential for clearing vertical integration after the SEC temporary registration filing. Growth risks include the 200 basis point decline in total options market share from 31.1% to 29.1% YoY in Q1 2026 [Cboe Q1 2026 Earnings, IR Cboe], which shows competitive erosion in multi-listed products even as the exclusive index franchise grows.
My estimate: sustainable normalized growth of 10-12% annually, below the 14.6% consensus but well above the 0.5% implied by reverse DCF.
Cboe possesses what is arguably one of the widest moats in financial services: exclusive licensing rights to SPX (S&P 500 Index) and VIX (Volatility Index) options through a contract with S&P Global [FinancialContent, February 2026]. These are the most liquid index options products in the world, and no competitor can replicate them. This represents an intangible asset moat of exceptional durability - the relationship dates to the VIX's creation in 1993, and switching costs for the institutional participants who depend on these instruments are astronomical.
The network effect compounds this: liquidity begets liquidity, and SPX options' deep order books make it extremely difficult for any competing index product to gain traction. Beyond the exclusive franchise, Cboe benefits from efficient scale in its exchange operations - the marginal cost of additional contracts is near zero, creating massive operating leverage. However, the moat is narrower in multi-listed equity options, where market share fell from 31.1% to 29.1% in one year due to aggressive competition from CME, Nasdaq PHLX, MIAX, and NYSE/ICE [Cboe Q1 2026 Earnings, IR Cboe].
The overall moat is wide due to the irreplaceability of the SPX/VIX franchise, but the trend outside that franchise is modestly eroding.
Cboe has experienced significant leadership turnover: former CEO Tilly resigned in late 2023 following a board investigation [Lowey Dannenberg, September 2023], interim CEO Tomczyk served through early 2025, and Craig Donohue was appointed CEO in May 2025 [Cboe CEO Appointment PR Newswire, 2025]. Donohue brings deep domain expertise from 20+ years at CME Group including 8 years as CEO, and his early actions suggest a disciplined operator: divesting non-core international businesses (Australia/Canada), pursuing cost reductions including explicit layoffs [Crain's Chicago Business, May 2026], and focusing capital on high-return opportunities in derivatives, digital assets, and prediction markets. The capital allocation record under the current board has been sound - maintaining a net cash position, growing dividends for 15 consecutive years, and selling assets at reasonable multiples.
Insider ownership at 0.27% is low, though this is typical for a $32B company. Net insider transactions show -2.39% (modest selling), with director Janet Froetscher selling $438K in May 2026 and various director stock awards. Institutional ownership at 92.9% is dominated by passive and long-only managers (Vanguard 12.8%, State Street, T.
Rowe Price) with no activist presence detected [Fintel.io, Investing.com]. The lack of activist interest is itself a positive signal - the company is generally well-run. Limitation: the CEO change is recent enough that the track record under Donohue remains unproven beyond initial strategic moves.
Key risks are moderate and well-identified. (1) Regulatory risk: Cboe's push into prediction markets and event contracts faces regulatory uncertainty. The SEC has been cautious about prediction markets, and competitors like Kalshi have faced regulatory challenges. Cboe's approach of wrapping prediction contracts in options structures [Cboe Prediction Markets PR Newswire, March 2026] may mitigate this but remains untested. (2) Concentration risk: the 10-K discloses that one customer accounted for a material portion of revenue in both 2024 and 2025, and the three largest clearing members accounted for a significant share of market maker transactions. (3) Competitive risk: the 200bp market share loss in multi-listed options in a single year is meaningful and could accelerate if rivals continue aggressive pricing.
Nasdaq's planned 23-hour trading expansion [Nasdaq report, December 2025] adds competitive pressure on equities. (4) Volatility dependency: while Cboe benefits from volatility (beta of just 0.44 shows it can even benefit when markets decline), a sustained low-volatility environment would compress options volumes and pricing. (5) CEO transition risk: Donohue has been in seat roughly 15 months, and the layoffs and restructuring could create execution risk. No material lawsuits or enforcement actions were identified in the most recent filings [SEC EDGAR 10-Q filings, 2026].
The securities and exchanges industry is on a constructive growth trajectory. The global market grew 7.2% to $2.37 trillion in 2026 [GlobeNewswire, March 2026], with the U.S. segment projected at 5.1% CAGR through 2031 [Mordor Intelligence]. Cboe sits at the center of multiple secular tailwinds: rising retail participation in options trading, the explosion of 0DTE contracts, growing demand for portfolio hedging, and the expansion of trading hours to serve global investors.
Cboe's strategic position is enviable - it controls the most important proprietary options products (SPX/VIX) while also operating competitive multi-listed venues across equity options, U.S. equities, European equities, futures, and FX. Institutional sentiment is positive: net institutional transactions are +1.93%, Morgan Stanley upgraded CBOE in April 2025 [Morgan Stanley, April 2025], and social sentiment scores average 6.7/10. The short float at 4.47% with 3.27 days to cover reflects modest bearish positioning.
Analyst consensus at 3.0 (hold) with a $308 target slightly below the current $310 price suggests the Street views it as fairly valued. The new extended trading hours initiative for single-stock options [Yahoo Finance, July 2026] and the clearing agency registration filing indicate the company is actively positioning for the next phase of market structure evolution.